Difference between revisions of "Team:Calgary/Gene Integration Diagram"

Line 33: Line 33:
 
                 <img class="fullpg" src="https://static.igem.org/mediawiki/2018/e/e0/T--Calgary--GeneInt.png">
 
                 <img class="fullpg" src="https://static.igem.org/mediawiki/2018/e/e0/T--Calgary--GeneInt.png">
 
                 <div style="padding: 10px">
 
                 <div style="padding: 10px">
−
                    <p>1. CRISPR/Cas9 wild-type binds targeted DNA location on the genome according to sgRNA homology
+
                  <ol>
−
                     </p>
+
  <li><p>1. CRISPR/Cas9 wild-type binds targeted DNA location on the genome according to sgRNA homology
−
                    <p>2. Cas9 wild-type cuts DNA in a double stranded fashion</p>
+
                     </p></li>
−
                     <p>3. The ssDNA insert brought in along with the RNP CRISPR complex is integrated into the genome</p>
+
  <li><p>2. Cas9 wild-type cuts DNA in a double stranded fashion</p></li>
−
                     <p>4. This integration happens via the non-homologous end joining DNA repair mechanism</p>
+
      <li><p>3. The ssDNA insert brought in along with the RNP CRISPR complex is integrated into the genome</p></li>
−
                     <p>5. This “landing pad” containing the FRT site is recognized by FlpO, which recombines with the
+
                     <li> <p>3. The ssDNA insert brought in along with the RNP CRISPR complex is integrated into the genome</p> </li>
 +
                     <li> <p>4. This integration happens via the non-homologous end joining DNA repair mechanism</p> </li>
 +
                     <li><p>5. This “landing pad” containing the FRT site is recognized by FlpO, which recombines with the
 
                         FRT site present on the plasmid, thus bringing in the entire plasmid into the genome</p>
 
                         FRT site present on the plasmid, thus bringing in the entire plasmid into the genome</p>
 
                     <ul>
 
                     <ul>
Line 44: Line 46:
 
                             assays, for use as a proof of concept
 
                             assays, for use as a proof of concept
 
                         </li>
 
                         </li>
−
                    </ul>
+
                      </ul></li>
−
                    <br>
+
                     <li><p>6. Within the genome, two sets of the Six 1, NPS, Six 2 combination are recognized by beta
−
                     <p>6. Within the genome, two sets of the Six 1, NPS, Six 2 combination are recognized by beta
+
                      resolvase, excising the sequences in-between</p></li>
−
                        resolvase, excising the sequences in-between</p>
+
                  </ol>
 +
                   
 +
                   
 +
                 
 +
                 
 +
                   
 +
               
  
 
                     <p>Result: Desired Product contains the puromycin gene, which is now active. The
 
                     <p>Result: Desired Product contains the puromycin gene, which is now active. The

Revision as of 22:15, 25 November 2018

Team:Calgary/Gene Integration Diagram - 2018.igem.org

GENE INTEGRATION DIAGRAM


  1. 1. CRISPR/Cas9 wild-type binds targeted DNA location on the genome according to sgRNA homology

  2. 2. Cas9 wild-type cuts DNA in a double stranded fashion

  3. 3. The ssDNA insert brought in along with the RNP CRISPR complex is integrated into the genome

  4. 3. The ssDNA insert brought in along with the RNP CRISPR complex is integrated into the genome

  5. 4. This integration happens via the non-homologous end joining DNA repair mechanism

  6. 5. This “landing pad” containing the FRT site is recognized by FlpO, which recombines with the FRT site present on the plasmid, thus bringing in the entire plasmid into the genome

    • The plasmid contains an inactive puromycin gene as the cargo, this is the case in our assays, for use as a proof of concept

  7. 6. Within the genome, two sets of the Six 1, NPS, Six 2 combination are recognized by beta resolvase, excising the sequences in-between

Result: Desired Product contains the puromycin gene, which is now active. The circularised/excised DNA is discarded, unable to return to the genome.